Please login to the form below

Not currently logged in
Email:
Password:

Karus names two division heads

Simon Roitt and Peter Finan strengthen research team

karus-Simon-RoittUK-based biopharma Karus Therapeutics has appointed new heads for two of its research divisions.

Dr Simon Roitt joins as head of clinical development and Dr Peter Finan joins as head of biology.

Dr Roitt (pictured right) is formerly director of clinical operations at Roche in the UK, a position he held for nine years. Prior to this he was director of clinical research at GE Healthcare in the UK.

His new colleague Dr Finan joins Karus from Novartis where he spent 16 years. Most recently he was VP, global head – respiratory disease.

In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

Dr Simon Kerry, chief executive of Karus said: “As we develop the business, the recruitment of highly experienced senior talent to our team will be a critical success factor. Simon and Peter both bring valuable clinical and scientific expertise to the Company, to help drive our programmes towards the clinic.”

29th October 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....